特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
936573

バイオ分析試験サービス市場:タイプ別(セルベースアッセイ、ウイルス学、血清学、バイオマーカー、薬物動態検査)、用途別、エンドユーザー別 - 2025年までの世界市場予測

Bioanalytical Testing Services Market by Type (Cell-based Assays, Virology, Serology, Biomarker, Pharmacokinetic Testing), Application, End User - Global Forecasts to 2025

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 204 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.35円
バイオ分析試験サービス市場:タイプ別(セルベースアッセイ、ウイルス学、血清学、バイオマーカー、薬物動態検査)、用途別、エンドユーザー別 - 2025年までの世界市場予測
出版日: 2020年05月13日
発行: MarketsandMarkets
ページ情報: 英文 204 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバイオ分析試験サービス市場は2020年の21億米ドルからCAGR11.8%で拡大し、2025年までに37億米ドルに達すると予測されています。生物製剤やバイオシミラーの分析試験への注目、分析試験のアウトソーシングの増加、医薬品業界、バイオ医薬品業界における研究開発費用の拡大、クオリティバイデザインアプローチの導入拡大などが市場の拡大を推進しています。しかし、熟練した専門家の不足が市場の成長を制限する大きな要因となるとみられています。

当レポートでは、世界のバイオ分析試験サービス市場について調査し、市場の概要とセグメント別動向、地域別動向、および参入企業のプロファイルについてまとめています。

936573_4.4 REGIONAL MIX BIOANALYTICAL TESTING SERVICES MARKET_FIGURE 14

第1章 イントロダクション

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 プレミアムインサイト

第5章 市場概要

  • イントロダクション
  • マクロ経済指標
  • 市場動向
    • 促進因子
    • 機会
    • 課題

第6章 タイプ別市場

  • イントロダクション
  • セルベースアッセイ
  • ウイルス検査
  • 手法開発最適化とバリデーション
  • 血清学、免疫遺伝子学、中和抗体
  • バイオマーカー検査
  • 薬物動態検査
  • その他のサービス

第7章 用途別市場

  • イントロダクション
  • 腫瘍
  • 神経
  • 感染症
  • 消化器
  • 心臓
  • その他

第8章 エンドユーザー別市場

  • イントロダクション
  • 製薬会社、バイオ医薬品企業
  • 受託開発・製造機関
  • CRO

第9章 地域別市場

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合環境

  • イントロダクション
  • 競合リーダーシップマッピング
  • 市場シェア分析
  • 地域別評価
  • 競合動向

第11章 企業プロファイル

第12章 付録

図表

LIST OF TABLES

  • TABLE 1 ANNUAL AVERAGE EXCHANGE RATES USED FOR CURRENCY CONVERSIONS TO USD
  • TABLE 2 PATENT EXPIRY OF BEST-SELLING BIOLOGICS
  • TABLE 3 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 4 BIOANALYTICAL TESTING SERVICES MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 5 BIOANALYTICAL TESTING SERVICES MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 6 BIOANALYTICAL TESTING SERVICES MARKET FOR BACTERIAL CELL-BASED ASSAYS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 7 BIOANALYTICAL TESTING SERVICES MARKET FOR VIRAL CELL-BASED ASSAYS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 8 BIOANALYTICAL TESTING SERVICES MARKET FOR VIROLOGY TESTING, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 9 BIOANALYTICAL TESTING SERVICES MARKET FOR VIROLOGY TESTING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 10 BIOANALYTICAL TESTING SERVICES MARKET FOR IN VITRO VIROLOGY TESTING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 11 BIOANALYTICAL TESTING SERVICES MARKET FOR IN VIVO VIROLOGY TESTING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 12 BIOANALYTICAL TESTING SERVICES MARKET FOR SPECIES-SPECIFIC VIRAL PCR ASSAYS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 13 BIOANALYTICAL TESTING SERVICES MARKET FOR METHOD DEVELOPMENT OPTIMIZATION AND VALIDATION, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 14 BIOANALYTICAL TESTING SERVICES MARKET FOR SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 15 BIOANALYTICAL TESTING SERVICES MARKET FOR BACTERIAL SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 16 BIOANALYTICAL TESTING SERVICES MARKET FOR VIRAL SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 17 BIOANALYTICAL TESTING SERVICES MARKET FOR BIOMARKER TESTING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 18 BIOANALYTICAL TESTING SERVICES MARKET FOR PHARMACOKINETIC TESTING, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 19 BIOANALYTICAL TESTING SERVICES MARKET FOR OTHER SERVICES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 20 BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 21 BIOANALYTICAL TESTING SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 22 LIST OF PIPELINE DRUGS FOR NEUROLOGICAL DISORDERS (2018)
  • TABLE 23 BIOANALYTICAL TESTING SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 24 BIOANALYTICAL TESTING SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 25 BIOANALYTICAL TESTING SERVICES MARKET FOR GASTROENTEROLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 26 LIST OF PIPELINE DRUGS FOR CARDIOVASCULAR DISEASES (2018)
  • TABLE 27 BIOANALYTICAL TESTING SERVICES MARKET FOR CARDIOLOGY, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 28 BIOANALYTICAL TESTING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 29 BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 30 BIOANALYTICAL TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 31 BIOANALYTICAL TESTING SERVICES MARKET FOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 32 BIOANALYTICAL TESTING SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 33 BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 34 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 35 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 36 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 37 NORTH AMERICA: VIROLOGY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 38 NORTH AMERICA: SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 39 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 40 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 41 KEY INDICATORS: US
  • TABLE 42 US: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 43 US: CELL-BASED ASSAYS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 44 US: VIROLOGY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 45 US: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 46 US: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 47 KEY INDICATORS: CANADA
  • TABLE 48 NUMBER OF ACTIVE CLINICAL TRIALS IN CANADA, BY CONDITION (2019)
  • TABLE 49 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 50 CANADA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 51 CANADA: VIROLOGY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 52 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 53 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 54 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 55 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 56 EUROPE: CELL-BASED ASSAYS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 57 EUROPE: VIROLOGY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 58 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 59 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 60 KEY INDICATORS: GERMANY
  • TABLE 61 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 62 GERMANY: CELL-BASED ASSAYS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 63 GERMANY: VIROLOGY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 64 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 65 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 66 KEY INDICATORS: FRANCE
  • TABLE 67 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 68 FRANCE: CELL-BASED ASSAYS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 69 FRANCE: VIROLOGY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 70 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 71 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 72 KEY INDICATORS: UK
  • TABLE 73 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 74 UK: CELL-BASED ASSAYS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 75 UK: VIROLOGY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 76 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 77 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 78 KEY INDICATORS: ITALY
  • TABLE 79 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 80 ITALY: CELL-BASED ASSAYS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 81 ITALY: VIROLOGY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 82 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 83 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 84 KEY INDICATORS: SPAIN
  • TABLE 85 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 86 SPAIN: CELL-BASED ASSAYS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 87 SPAIN: VIROLOGY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 88 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 89 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 90 ROE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 91 ROE: CELL-BASED ASSAYS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 92 ROE: VIROLOGY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 93 ROE: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 94 ROE: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 95 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 96 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 98 ASIA PACIFIC: VIROLOGY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 99 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 100 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 101 KEY INDICATORS: CHINA
  • TABLE 102 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 103 CHINA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 104 CHINA: VIROLOGY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 105 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 106 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 107 KEY INDICATORS: JAPAN
  • TABLE 108 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 109 JAPAN: CELL-BASED ASSAYS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 110 JAPAN: VIROLOGY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 111 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 112 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 113 INCREASE IN THE R&D EXPENDITURE OF THE TOP 5 INDIAN PHARMACEUTICAL COMPANIES (2010 VS. 2018)
  • TABLE 114 KEY INDICATORS: INDIA
  • TABLE 115 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 116 INDIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 117 INDIA: VIROLOGY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 118 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 119 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 120 ROAPAC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 121 ROAPAC: CELL-BASED ASSAYS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 122 ROAPAC: VIROLOGY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 123 ROAPAC: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 124 ROAPAC: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 125 NUMBER OF CLINICAL TRIALS IN LATINA AMERICA, BY COUNTRY (JUNE 2019)
  • TABLE 126 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 127 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 128 LATIN AMERICA: VIROLOGY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 129 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 130 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 131 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 132 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 133 MIDDLE EAST & AFRICA: VIROLOGY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 134 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 135 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018-2025 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 BIOANALYTICAL TESTING SERVICES MARKET SEGMENTATION
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS
  • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • FIGURE 7 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
  • FIGURE 8 BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
  • FIGURE 9 BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
  • FIGURE 10 BIOANALYTICAL TESTING SERVICES MARKET: REGIONAL SNAPSHOT
  • FIGURE 11 RISING FOCUS ON THE ANALYTICAL TESTING OF BIOLOGICS AND BIOSIMILARS TO DRIVE MARKET GROWTH
  • FIGURE 12 ONCOLOGY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC BIOANALYTICAL TESTING SERVICES MARKET IN 2019
  • FIGURE 13 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 14 NORTH AMERICA WILL CONTINUE TO DOMINATE THE BIOANALYTICAL TESTING SERVICES MARKET DURING THE FORECAST PERIOD
  • FIGURE 15 DEVELOPING COUNTRIES TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD
  • FIGURE 16 BIOANALYTICAL TESTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17 PHARMACEUTICAL & BIOPHARMACEUTICAL R&D EXPENDITURE, 2017-2024
  • FIGURE 18 NUMBER OF REGISTERED STUDIES, 2001-2019
  • FIGURE 19 NUMBER OF PIPELINE DRUGS, BY COMPANY, 2019
  • FIGURE 20 GLOBAL NUMBER OF CLINICAL TRIALS IN DIFFERENT THERAPEUTIC AREAS, 2015-2018
  • FIGURE 21 WORLDWIDE CANCER INCIDENCE AND MORTALITY (2018-2040)
  • FIGURE 22 ANNUAL DRUG APPROVALS BY CDER (2010-2019)
  • FIGURE 23 PHARMACEUTICAL R&D SPENDING, 2010-2018
  • FIGURE 24 ACTIVE PHARMACEUTICAL PIPELINE, 2001-2019
  • FIGURE 25 CHINA IS EXPECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 26 TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA (2019)
  • FIGURE 27 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET SNAPSHOT
  • FIGURE 28 US: PIPELINE SPLIT OF PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY PHASE (JANUARY 2019)
  • FIGURE 29 TOTAL R&D EXPENDITURE OF THE US PHARMACEUTICAL INDUSTRY (2010-2018)
  • FIGURE 30 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET SNAPSHOT
  • FIGURE 31 UK: PHARMACEUTICAL R&D EXPENDITURE, 2013-2017 (USD BILLION)
  • FIGURE 32 UK: COMMERCIAL CLINICAL TRIAL APPLICATIONS, BY PHASE, 2013-2017
  • FIGURE 33 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET SNAPSHOT
  • FIGURE 34 KEY DEVELOPMENTS IN THE BIOANALYTICAL TESTING SERVICES MARKET
  • FIGURE 35 BIOANALYTICAL TESTING SERVICES MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019
  • FIGURE 36 MARKET SHARE ANALYSIS: BIOANALYTICAL TESTING SERVICES MARKET (2019)
  • FIGURE 37 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE BIOANALYTICAL TESTING SERVICES MARKET (2018)
  • FIGURE 38 CHARLES RIVER: COMPANY SNAPSHOT (2019)
  • FIGURE 39 MEDPACE: COMPANY SNAPSHOT (2018)
  • FIGURE 40 WUXI APPTEC: COMPANY SNAPSHOT (2018)
  • FIGURE 41 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
  • FIGURE 42 IQVIA INC.: COMPANY SNAPSHOT (2019)
  • FIGURE 43 SGS SA: COMPANY SNAPSHOT (2019)
  • FIGURE 44 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT (2019)
  • FIGURE 45 INTERTEK GROUP PLC: COMPANY SNAPSHOT (2019)
  • FIGURE 46 PRA HEALTH SCIENCES: COMPANY SNAPSHOT (2019)
  • FIGURE 47 SYNEOS HEALTH: COMPANY SNAPSHOT (2019)
  • FIGURE 48 ICON PLC: COMPANY SNAPSHOT (2019)
  • FIGURE 49 FRONTAGE LABS: COMPANY SNAPSHOT (2018)
目次
Product Code: AST 7644

"Rising focus on the analytical testing of biologics and biosimilars to drive market growth"

The global bioanalytical testing services market is projected to reach USD 3.7 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 11.8% during the forecast period. The growth in this market is attributed to the rising focus on the analytical testing of biologics and biosimilars, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design approach. However, the dearth of skilled professionals is a major factor that is expected to restrain the growth of this market during the forecast period.

"Pharmaceutical and biopharmaceutical companies were the largest end users of bioanalytical testing services in 2019"

Based on end user, the bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations, and contract research organizations. In 2019, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the bioanalytical testing services market. The large share of this segment can be attributed to the increased outsourcing of early-phase development, clinical, and laboratory testing services by pharmaceutical companies to boost profit margins, avoid high capital expenditure, and reduce the time duration to validate processes and products.

"Oncology is the largest application segment in the bioanalytical testing services market"

Based on the application area, the bioanalytical testing services market is broadly categorized into oncology, neurology, infectious diseases, gastroenterology, cardiology, and other applications. Oncology is the largest application segment in this market, primarily due to the increasing number of clinical trials conducted for oncology and the rising prevalence of cancer worldwide.

"North America will continue to dominate the bioanalytical testing services market in 2025"

The bioanalytical testing services market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America accounted for the largest share of the bioanalytical testing services market. The large share of North America in this market can be attributed to the high-quality standards in the pharmaceutical industry, rapid growth in the biosimilars and biologics markets, and an increase in clinical trial activity in the region.

The break-down of primary participants is as mentioned below:

  • By Company Type - Tier 1: 35%, Tier 2: 45%, and Tier 3: 20%
  • By Designation - C-level: 30%, Director-level: 55%, and Others: 15%
  • By Region - North America: 40%, Europe: 25%, Asia Pacific: 20%, Latin America: 10%, and the Middle East & Africa: 5%

The prominent players operating in the bioanalytical testing services market include Charles River (US), Medpace (US), WuXi AppTec (China), Eurofins Scientific (Luxembourg), IQVIA, Inc. (US), SGS SA (Switzerland), Laboratory Corporation of America Holdings (US), Intertek Group plc (UK), PRA Health Sciences (US), Syneos Health (US), ICON plc (Ireland), Frontage Labs (US), PPD, Inc. (US), PAREXEL International Corporation (US), Almac Group (UK), Celerion (US), Altasciences (US), BioAgilytix Labs (US), Lotus Labs Pvt. Ltd. (India), and LGS Limited (UK).

Research Coverage:

The report analyzes the bioanalytical testing services market and aims at estimating the market size and future growth potential of various market segments, based on type, application, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report:

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the bioanalytical testing services market. The report analyzes this market by type, application, end user, and region
  • Market Development: Comprehensive information on the lucrative emerging markets, by type, application, end user, and region
  • Market Diversification: Exhaustive information about the service portfolios, growing geographies, recent developments, and investments in the bioanalytical testing services market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the bioanalytical testing services market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION & SCOPE
    • 1.2.1 MARKETS COVERED
    • 1.2.2 YEARS CONSIDERED FOR THE STUDY
  • 1.3 CURRENCY
  • 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
  • 2.4 MARKET RANKING ANALYSIS
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 BIOANALYTICAL TESTING SERVICES MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION & COUNTRY (2019)
  • 4.3 BIOANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4 REGIONAL MIX: BIOANALYTICAL TESTING SERVICES MARKET
  • 4.5 BIOANALYTICAL TESTING SERVICES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising focus on the analytical testing of biologics and biosimilars
      • 5.2.1.2 Increasing preference for outsourcing analytical testing
      • 5.2.1.3 Growing R&D expenditure in the pharmaceutical and biopharmaceutical industry
      • 5.2.1.4 Rising adoption of the Quality by Design approach
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Dearth of skilled professionals
      • 5.2.2.2 Pricing pressure faced by major players
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emerging countries in the Asia Pacific region
      • 5.2.3.2 Rising demand for specialized bioanalytical testing services
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Innovative formulations demanding a unique bioanalytical testing approach
      • 5.2.4.2 Growing need to improve the sensitivity of bioanalytical methods

6 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 CELL-BASED ASSAYS
    • 6.2.1 BACTERIAL CELL-BASED ASSAYS
      • 6.2.1.1 Bacterial cell-based assays segment to dominate the bioanalytical testing services market for cell-based assays
    • 6.2.2 VIRAL CELL-BASED ASSAYS
      • 6.2.2.1 Increasing outbreaks of viral diseases to support the growth of this market segment
  • 6.3 VIROLOGY TESTING
    • 6.3.1 IN VITRO VIROLOGY TESTING
      • 6.3.1.1 Higher uptake of in vitro virology assays in the development of antiviral pharmaceuticals to drive the growth of this market segment
    • 6.3.2 IN VIVO VIROLOGY TESTING
      • 6.3.2.1 High utilization of in vivo assays during important production phases to drive their demand
    • 6.3.3 SPECIES-SPECIFIC VIRAL PCR ASSAYS
      • 6.3.3.1 Wide application of species-specific viral PCR assays in the detection of viral risks to support the growth of this market segment
  • 6.4 METHOD DEVELOPMENT OPTIMIZATION AND VALIDATION
    • 6.4.1 MANDATORY REQUIREMENT BY REGULATORY AUTHORITIES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
  • 6.5 SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES
    • 6.5.1 INCREASING APPLICATIONS OF SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
    • 6.5.2 BACTERIAL SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES
    • 6.5.3 VIRAL SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES
  • 6.6 BIOMARKER TESTING
    • 6.6.1 EMPHASIS ON THE DEVELOPMENT OF PERSONALIZED MEDICINE TO DRIVE THE DEMAND FOR BIOMARKER TESTING SERVICES
  • 6.7 PHARMACOKINETIC TESTING
    • 6.7.1 INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE THE DEMAND FOR PHARMACOKINETIC TESTING SERVICES
  • 6.8 OTHER SERVICES

7 BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 ONCOLOGY
    • 7.2.1 ONCOLOGY IS THE LARGEST APPLICATION SEGMENT IN THE BIOANALYTICAL TESTING SERVICES MARKET
  • 7.3 NEUROLOGY
    • 7.3.1 ROBUST PIPELINE OF DRUGS FOR CNS DISEASES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
  • 7.4 INFECTIOUS DISEASES
    • 7.4.1 OUTBREAK OF COVID-19 TO BOOST THE GROWTH OF THIS MARKET SEGMENT
  • 7.5 GASTROENTEROLOGY
    • 7.5.1 RISING PREVALENCE OF CHRONIC DIGESTIVE DISORDERS TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT
  • 7.6 CARDIOLOGY
    • 7.6.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT
  • 7.7 OTHER APPLICATIONS

8 BIOANALYTICAL TESTING SERVICES MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
    • 8.2.1 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES ARE THE LARGEST END USERS OF BIOANALYTICAL TESTING SERVICES
  • 8.3 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS
    • 8.3.1 CDMOS PROVIDE SERVICES SUCH AS ANALYTICAL DEVELOPMENT, FORMULATION SCREENING AND DEVELOPMENT, STABILITY STUDIES, AND PRE-CLINICAL SAFETY ASSESSMENT STUDIES
  • 8.4 CONTRACT RESEARCH ORGANIZATIONS
    • 8.4.1 CONTRACT RESEARCH ORGANIZATIONS ARE INCREASINGLY SUBCONTRACTING THEIR ACTIVITIES TO NICHE LABORATORIES SPECIALIZED IN PROVIDING BIOANALYTICAL TESTING SERVICES

9 BIOANALYTICAL TESTING SERVICES MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
      • 9.2.1.1 US is the largest market for bioanalytical testing services in North America
    • 9.2.2 CANADA
      • 9.2.2.1 Increasing number of clinical trials in Canada to support market growth
  • 9.3 EUROPE
    • 9.3.1 GERMANY
      • 9.3.1.1 Government support and flexible labor laws have made Germany a favorable location for clinical trials
    • 9.3.2 FRANCE
      • 9.3.2.1 High number of oncology clinical trials in France to drive market growth
    • 9.3.3 UK
      • 9.3.3.1 Investment by pharmaceutical sponsors in the UK for drug discovery services to support market growth
    • 9.3.4 ITALY
      • 9.3.4.1 Low drug approval time in Italy, along with the growing number of clinical trials, to drive market growth
    • 9.3.5 SPAIN
      • 9.3.5.1 Short study start-up times and rising R&D expenditure to boost the growth of the Spanish market
    • 9.3.6 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 CHINA
      • 9.4.1.1 China is the largest market for bioanalytical testing services in the Asia Pacific
    • 9.4.2 JAPAN
      • 9.4.2.1 Rising geriatric population to drive market growth in Japan
    • 9.4.3 INDIA
      • 9.4.3.1 Growing pharmaceutical industry in India to drive market growth
    • 9.4.4 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 GROWING R&D EXPENDITURE IN THE PHARMACEUTICAL AND BIOPHARMACEUTICAL SECTOR TO DRIVE MARKET GROWTH IN LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET GROWTH IN THE MIDDLE EAST AND AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 COMPETITIVE LEADERSHIP MAPPING
    • 10.2.1 VISIONARY LEADERS
    • 10.2.2 INNOVATORS
    • 10.2.3 DYNAMIC DIFFERENTIATORS
    • 10.2.4 EMERGING COMPANIES
  • 10.3 BIOANALYTICAL TESTING SERVICES MARKET SHARE ANALYSIS
  • 10.4 BIOANALYTICAL TESTING SERVICES MARKET: GEOGRAPHICAL ASSESSMENT
  • 10.5 COMPETITIVE SITUATIONS & TRENDS
    • 10.5.1 SERVICE LAUNCHES (2017-2020)
    • 10.5.2 EXPANSIONS (2019-2020)
    • 10.5.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2019-2020)
    • 10.5.4 ACQUISITIONS (2019)
    • 10.5.5 OTHER DEVELOPMENTS (2019)

11 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, Strategic Overview, MnM View)*

  • 11.1 CHARLES RIVER
  • 11.2 MEDPACE
  • 11.3 WUXI APPTEC
  • 11.4 EUROFINS SCIENTIFIC
  • 11.5 IQVIA INC.
  • 11.6 SGS SA
  • 11.7 LABORATORY CORPORATION OF AMERICA HOLDINGS
  • 11.8 INTERTEK GROUP PLC
  • 11.9 PRA HEALTH SCIENCES
  • 11.10 SYNEOS HEALTH
  • 11.11 ICON PLC
  • 11.12 FRONTAGE LABS
  • 11.13 PPD, INC.
  • 11.14 PAREXEL INTERNATIONAL CORPORATION
  • 11.15 ALMAC GROUP
  • 11.16 CELERION
  • 11.17 ALTASCIENCES
  • 11.18 BIOAGILYTIX LABS
  • 11.19 LOTUS LABS PVT. LTD.
  • 11.20 LGC LIMITED

Business Overview, Products Offered, Recent Developments, Strategic Overview, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.